Half-year report · HY
4594.TEDINET S100X388
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥33,000 | 2025-04-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1m | 2024-04-01 → 2025-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥56,000 | 2024-04-01 → 2024-09-30 | Standalone | Net sales |
| Operating income | −¥465m | 2025-04-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥543m | 2024-04-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥461m | 2025-04-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥538m | 2024-04-01 → 2024-09-30 | Standalone | Ordinary income |
| Profit before tax | −¥462m | 2025-04-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥538m | 2024-04-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥463m | 2025-04-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥539m | 2024-04-01 → 2024-09-30 | Standalone | Profit loss |
| Total assets | ¥1.7bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥1.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.7bn | at 2024-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥171m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥196m | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.5bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥925m | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥810m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥810m | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥591m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥521m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥2m | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2025-04-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.53 | 2025-04-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.12 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.11 | 2024-04-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 88.7% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.4% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 111,391,300 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 90,491,300 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 83,791,300 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 358
| Item | Context | Value | Unit |
|---|---|---|---|
| Retirement benefit expenses sga | InterimDuration_NonConsolidatedMember | － | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第23期中(自 2025年４月１日 至 2025年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ブライトパス・バイオ株式会社 | |
| Company name in english cover page | FilingDateInstant | BrightPath Biotherapeutics Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 永井 健一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)神奈川県川崎市川崎区殿町三丁目25番22号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 044-440-3939 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理部長 白石 直織 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区麹町二丁目２番地４ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-5840-7697(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理部長 白石 直織 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E31851 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45940 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ブライトパス・バイオ株式会社 | |
| Filer name in english | FilingDateInstant | BrightPath Biotherapeutics Co., Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2025-09-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |